Glycopyrrolate: all 130 studies that test it
Page 2 of 2. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- Lung Deposition of Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide Administered Via pMDI in Healthy, Asthmatic and COPD PatientsCompletedNCT02975843Phase 1
- Effect of a LAMA and a uLABA on the Methacholine Dose-response CurveCompletedNCT02953041Phase 4
- Effects of Long Acting Bronchodilators on CARDiac Autonomic Control in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02872090Phase 4
- Prevention of Postoperative Events Following Reversal With Sugammadex or NeostigmineTerminatedNCT02825576Phase 4
- A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated EosinophilsTerminatedNCT02693769Phase 2/3
- Duration of Long Acting Muscarinic Antagonist (LAMA) Bronchoprotection Against Methacholine ChallengeCompletedNCT02622243Phase 4
- Clozapine-induced Hypersalivation - Feasibility TrialCompletedNCT02613494Phase 1/2
- Anticholinergic Premedication Induced Fever in Pediatric Ambulatory Anesthesia With KetamineCompletedNCT02430272Not applicable
- Study of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's DiseaseStatus unknownNCT02382198Phase 2
- "Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"CompletedNCT02375217Phase 4
- Transdermal Administration of a Prokinetic Agent for Bowel Evacuation in Persons With SCICompletedNCT02370862Early Phase 1
- Use of Prokinetics During Inpatient Bowel Care for SCI PatientsStatus unknownNCT02370433Phase 1
- Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder DiscomfortStatus unknownNCT02228473Not applicable
- Efficacy and Safety of Glycopyrrolate Bromide of COPD PatientsCompletedNCT02189577Phase 2
- Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled AsthmaWithdrawnNCT02127697Phase 3
- Pharmacokinetics of CHF 5993 pMDI With and Without Spacer in COPD PatientsCompletedNCT02119234Phase 1
- A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment.CompletedNCT02040597Phase 1
- Efficacy of NVA237 (50 μg o.d) Using Tiotropium (5μg μg o.d) as Active Control in COPD Patients.WithdrawnNCT01837927Phase 3
- Safety and Efficacy of NVA237 as an add-on to Fixed Dose Combination LABA/ICSWithdrawnNCT01757015Phase 3
- Dose Ranging Study of Glycopyrronium Bromide in Patients With Moderate or Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01703624Phase 2
- Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal ImpairmentCompletedNCT01613690Phase 1
- Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Glycopyrrolate (AIDES-G)TerminatedNCT01588717Phase 1
- Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and GlycopyrrolateCompletedNCT01476813Phase 2
- Street Fitness in Surgical Patients Undergoing General Anesthesia After Reversal of Neuromuscular BlockadeStatus unknownNCT01453530Phase 4
- Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy VolunteersCompletedNCT01398111Phase 1
- Safety and Efficacy Study of Glyco pMDI After Single and Repeated AdministrationCompletedNCT01176903Phase 1/2
- Biopharmaceutical Study of Glyco pMDI With or Without Charcoal Block vs IV Bolus in Healthy VolunteersCompletedNCT01176851Phase 1
- Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00871182Phase 1/2
- Safety and Tolerability of Multiple Inhaled NVA237 Doses in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00545311Phase 1
- A Study to Assess the Safety and Efficacy of Different AD 237 Doses in Adults With COPDCompletedNCT00242333Phase 2